Arne Klungland is a Professor and Centre Director at the Centre for Embryology and Healthy Development (CRESCO), affiliated with the University of Oslo and Oslo University Hospital. His research spans molecular biology, epigenetics, DNA repair, and embryology, with a focus on RNA modifications such as m6A and m1A methylation. University: University of Oslo School: Faculty of Medicine Department: Centre for Embryology and Healthy Development (CRESCO) Academic Rank: Professor Email: arne.klungland@medisin.uio.no His research interests include epigenetics, epitranscriptomics, DNA repair, meiosis, and embryology. His work investigates how RNA modifications regulate gene expression during development and disease, particularly in gametogenesis, stem cell biology, and cancer. He has made significant contributions to understanding m6A and m1A dynamics in mammalian systems. The recent articles highlight a strong trend in RNA epigenetics, particularly m6A and m1A modifications in embryonic development, stem cells, and cancer. His research integrates high-throughput sequencing, molecular biology, and functional genomics to explore post-transcriptional regulation in development and disease. Scientific awards are not mentioned in the provided text. Klungland leads a dynamic research group at CRESCO, mentoring students and postdoctoral researchers. He has been involved in numerous collaborative research projects on DNA repair, RNA modifications, and developmental biology. His lab utilizes advanced techniques such as single-cell RNA mapping, ChIP, and functional assays in mouse and human models. While specific grant details are not listed, his consistent publication in top journals indicates sustained funding and research activity. He leads the Centre for Embryology and Healthy Development (CRESCO), a multidisciplinary research center focused on understanding molecular mechanisms of embryogenesis, fertility, and developmental disorders. The center fosters collaboration between basic scientists and clinicians to translate findings into improved reproductive health outcomes.